AFPL
GILD icon

Advus Financial Partners, LLC’s Gilead Sciences GILD Stock Holding History

Advus Financial Partners, LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719K Sell
5,689
-147
-3% -$19.4K 0.16% 99
2026
Q1 		$813K Sell
5,836
-30
-0.5% -$4.2K 0.2% 84
2025
Q4 		$720K Sell
5,866
-1,352
-19% -$164K 0.17% 88
2025
Q3 		$801K Buy
7,218
+445
+7% +$50.6K 0.19% 82
2025
Q2 		$751K Buy
6,773
+1,243
+22% +$132K 0.19% 83
2025
Q1 		$620K Buy
5,530
+1,077
+24% +$111K 0.17% 86
2024
Q4 		$411K Buy
4,453
+669
+18% +$60.2K 0.12% 122
2024
Q3 		$317K Buy
3,784
+81
+2% +$6.18K 0.09% 150
2024
Q2 		$254K Sell
3,703
-207
-5% -$13.8K 0.08% 167
2024
Q1 		$286K Buy
3,910
+617
+19% +$47.4K 0.09% 155
2023
Q4 		$267K Buy
3,293
+90
+3% +$7K 0.09% 144
2023
Q3 		$240K Sell
3,203
-610
-16% -$46.9K 0.09% 130
2023
Q2 		$294K Buy
3,813
+316
+9% +$25.2K 0.11% 109
2023
Q1 		$290K Buy
3,497
+169
+5% +$14K 0.12% 104
2022
Q4 		$286K Buy
+3,328
New +$264K 0.12% 106

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advus Financial Partners, LLC's GILD Position: Q2 2026 in Review

Advus Financial Partners, LLC reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $19.4K and leaving 5,689 shares worth $719K. The position accounts for 0.16% of the portfolio, ranked #99.

Advus Financial Partners, LLC first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $813K in Q1 2026. 2,271 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Advus Financial Partners, LLC held 5,689 shares of Gilead Sciences worth $719K as of Q2 2026.
  • Advus Financial Partners, LLC sold 147 Gilead Sciences shares in Q2 2026, an estimated $19.4K.
  • Gilead Sciences made up 0.16% of Advus Financial Partners, LLC's portfolio in Q2 2026, its #99 holding.
  • Advus Financial Partners, LLC first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Advus Financial Partners, LLC's Gilead Sciences position peaked at $813K in Q1 2026.
  • 2,271 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Advus Financial Partners, LLC's 13F filing for Q2 2026, filed 25 Aug 2026.